Pub Date : 2025-11-01DOI: 10.1016/j.piel.2025.02.003
Micaela Guglielmetti Macchiavello , Hans Walter Gubelin Alvarado
{"title":"Rol de la terapia láser en el campo de cancerización cutáneo","authors":"Micaela Guglielmetti Macchiavello , Hans Walter Gubelin Alvarado","doi":"10.1016/j.piel.2025.02.003","DOIUrl":"10.1016/j.piel.2025.02.003","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 9","pages":"Pages 553-557"},"PeriodicalIF":0.0,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145442270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Superficial mycoses are fungal infections involving skin, hair and nails with exceptional systemic involvement. Treatment varies according to the clinical context and the microorganism involved in each patient. This review summarizes the treatment recommendations for superficial mycoses according to current evidence.
{"title":"Micosis superficiales: novedades del tratamiento antifúngico","authors":"Daniela Morales Restrepo , Aura Sofía Arteaga Calderón , Isabela Agudelo Aguilar , Valentina Rodelo Sánchez","doi":"10.1016/j.piel.2025.01.012","DOIUrl":"10.1016/j.piel.2025.01.012","url":null,"abstract":"<div><div>Superficial mycoses are fungal infections involving skin, hair and nails with exceptional systemic involvement. Treatment varies according to the clinical context and the microorganism involved in each patient. This review summarizes the treatment recommendations for superficial mycoses according to current evidence.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 524-532"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.piel.2024.11.009
Cristina Carrión García , Eduardo Esteban Garrido , Anastasia Alejandra Garrido Ríos , Ana Hernando García , Begoña Echeverría García , Jesús Borbujo
{"title":"Fístula arteriovenosa dural del cuero cabelludo: la utilidad de la ecografía cutánea en el diagnóstico","authors":"Cristina Carrión García , Eduardo Esteban Garrido , Anastasia Alejandra Garrido Ríos , Ana Hernando García , Begoña Echeverría García , Jesús Borbujo","doi":"10.1016/j.piel.2024.11.009","DOIUrl":"10.1016/j.piel.2024.11.009","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 534-536"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145216288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.piel.2024.11.019
Marina de la Puente Alonso , Jorge Martín-Nieto González , Luis Ángel Zamarro Díaz , Paloma García Piqueras
{"title":"Síndrome de Stevens-Johnson por alopurinol en una mujer portadora del alelo HLA-B*58:01","authors":"Marina de la Puente Alonso , Jorge Martín-Nieto González , Luis Ángel Zamarro Díaz , Paloma García Piqueras","doi":"10.1016/j.piel.2024.11.019","DOIUrl":"10.1016/j.piel.2024.11.019","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 549-551"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145222885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.piel.2024.11.013
Ana Jiménez-Sánchez, María Olivares-Guerrero, Clara Buendía-Martínez, Diego de Argila
{"title":"Nuevas manifestaciones cutáneas en el síndrome antisintetasa con anticuerpos anti-EJ","authors":"Ana Jiménez-Sánchez, María Olivares-Guerrero, Clara Buendía-Martínez, Diego de Argila","doi":"10.1016/j.piel.2024.11.013","DOIUrl":"10.1016/j.piel.2024.11.013","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 538-541"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.piel.2025.02.005
Juan Jacobo Del Valle Saavedra , Olga Lucía Agudelo Rojas , Paola Andrea Rueda Galvis , Daniela Zuluaga Lotero , Laura Margarita Arango Bedoya , Aura Sofía Arteaga Calderón , Isabela Agudelo Aguilar , Elsa María Vásquez Trespalacios , Angela María Londoño García , Sara Saldarriaga Santamaría
Introduction
Atopic dermatitis is an inflammatory skin disease that is part of the atopic spectrum, and it has the highest disease burden among all dermatoses. The objective of the study is to analyze the response to treatment of patients diagnosed with atopic dermatitis who received narrow-band UVB phototherapy (UVB NB).
Methods
A descriptive follow-up study was carried out on a cohort where information was retrospectively collected from 280 patients who attended UVB NB phototherapy in a reference center between 2015 and 2022. The definition of improvement was determined by a decrease in the symptoms of eczematous lesions and the clinical control of the disease without relapse in the follow-up observed in the patient controls. In the statistical analysis, the results of the continuous variables were expressed in means and standard deviation and a bivariate analysis of nominal variables was performed.
Results
The improvement rate was 72.14% of patients, 69.8% in women, with an average patient age of 21.22 ± 11.65 years. The average number of sessions to observe response was 16.8 sessions, which takes approximately between 5.6 and 8.4 weeks. It was significantly associated with tolerance to phototherapy, the number of sessions and the highest tolerated dose.
Conclusions
UVB NB phototherapy achieves improvement in patients with atopic dermatitis. The need for a controlled sample in the future will be necessary to determine its greater effectiveness and determine its relationship with factors associated with the disease.
{"title":"Factores asociados a la respuesta al tratamiento con fototerapia en pacientes con dermatitis atópica","authors":"Juan Jacobo Del Valle Saavedra , Olga Lucía Agudelo Rojas , Paola Andrea Rueda Galvis , Daniela Zuluaga Lotero , Laura Margarita Arango Bedoya , Aura Sofía Arteaga Calderón , Isabela Agudelo Aguilar , Elsa María Vásquez Trespalacios , Angela María Londoño García , Sara Saldarriaga Santamaría","doi":"10.1016/j.piel.2025.02.005","DOIUrl":"10.1016/j.piel.2025.02.005","url":null,"abstract":"<div><h3>Introduction</h3><div>Atopic dermatitis is an inflammatory skin disease that is part of the atopic spectrum, and it has the highest disease burden among all dermatoses. The objective of the study is to analyze the response to treatment of patients diagnosed with atopic dermatitis who received narrow-band UVB phototherapy (UVB NB).</div></div><div><h3>Methods</h3><div>A descriptive follow-up study was carried out on a cohort where information was retrospectively collected from 280 patients who attended UVB NB phototherapy in a reference center between 2015 and 2022. The definition of improvement was determined by a decrease in the symptoms of eczematous lesions and the clinical control of the disease without relapse in the follow-up observed in the patient controls. In the statistical analysis, the results of the continuous variables were expressed in means and standard deviation and a bivariate analysis of nominal variables was performed.</div></div><div><h3>Results</h3><div>The improvement rate was 72.14% of patients, 69.8% in women, with an average patient age of 21.22 ± 11.65 years. The average number of sessions to observe response was 16.8 sessions, which takes approximately between 5.6 and 8.4 weeks. It was significantly associated with tolerance to phototherapy, the number of sessions and the highest tolerated dose.</div></div><div><h3>Conclusions</h3><div>UVB NB phototherapy achieves improvement in patients with atopic dermatitis. The need for a controlled sample in the future will be necessary to determine its greater effectiveness and determine its relationship with factors associated with the disease.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 481-487"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Historically, the importance of the human microbiota has been recognised, along with its role in homeostasis and pathogenesis. The purpose of this review is to analyse the role of probiotics in the treatment of various dermatological pathologies, such as acne, atopic dermatitis, wound healing, and aging. We want to evaluate the evidence on how they can reduce inflammation, proliferation of different microorganisms causing the mentioned pathologies, and the colonization of some pathogens, obtaining immunomodulatory effects, improving skin appearance, and helping to prevent infections. However, it is important to consider the need for the selection of specific probiotic strains for each dermatological pathology, highlighting the interconnection between the skin and other systems, such as the gastrointestinal and central nervous systems, which opens up new pathways for personalized, targeted, and effective treatments in dermatology.
{"title":"Probióticos en dermatología: ¿tienen algún papel?","authors":"Maria Cristina Navarro Escudero , Sofía González Velásquez , Andrés Calle Meneses","doi":"10.1016/j.piel.2025.01.008","DOIUrl":"10.1016/j.piel.2025.01.008","url":null,"abstract":"<div><div>Historically, the importance of the human microbiota has been recognised, along with its role in homeostasis and pathogenesis. The purpose of this review is to analyse the role of probiotics in the treatment of various dermatological pathologies, such as acne, atopic dermatitis, wound healing, and aging. We want to evaluate the evidence on how they can reduce inflammation, proliferation of different microorganisms causing the mentioned pathologies, and the colonization of some pathogens, obtaining immunomodulatory effects, improving skin appearance, and helping to prevent infections. However, it is important to consider the need for the selection of specific probiotic strains for each dermatological pathology, highlighting the interconnection between the skin and other systems, such as the gastrointestinal and central nervous systems, which opens up new pathways for personalized, targeted, and effective treatments in dermatology.</div></div>","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 498-503"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145223076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01DOI: 10.1016/j.piel.2024.11.018
Juan Pablo Velasco-Amador, María José Naranjo-Díaz, Marta Cebolla-Verdugo, Ricardo Ruiz-Villaverde
{"title":"Hiperplasia angiolinfoide con eosinofilia asociada a escabiosis","authors":"Juan Pablo Velasco-Amador, María José Naranjo-Díaz, Marta Cebolla-Verdugo, Ricardo Ruiz-Villaverde","doi":"10.1016/j.piel.2024.11.018","DOIUrl":"10.1016/j.piel.2024.11.018","url":null,"abstract":"","PeriodicalId":20182,"journal":{"name":"Piel","volume":"40 8","pages":"Pages 545-547"},"PeriodicalIF":0.0,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145222888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号